Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 100 shares at $1048.54 ($105K) on 2024-10-01, disclosed to the SEC on 2024-10-03.
Scheduled sale ($105k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1041.35 | 3 | $3K | 3.0% |
| 2 | $1042.31 | 1 | $1K | 1.0% |
| 3 | $1043.39 | 5 | $5K | 5.0% |
| 4 | $1044.62 | 9 | $9K | 9.0% |
| 5 | $1045.27 | 7 | $7K | 7.0% |
| 6 | $1046.53 | 9 |
| $9K |
| 9.0% |
| 7 | $1047.44 | 12 | $13K | 12.0% |
| 8 | $1048.54 | 12 | $13K | 12.0% |
| 9 | $1049.68 | 9 | $9K | 9.0% |
| 10 | $1050.60 | 6 | $6K | 6.0% |
| 11 | $1051.51 | 9 | $9K | 9.0% |
| 12 | $1052.44 | 4 | $4K | 4.0% |
| 13 | $1053.45 | 4 | $4K | 4.0% |
| 14 | $1054.90 | 3 | $3K | 3.0% |
| 15 | $1056.68 | 3 | $3K | 3.0% |
| 16 | $1057.38 | 2 | $2K | 2.0% |
| 17 | $1059.28 | 2 | $2K | 2.0% |
| Total | $1048.78 avg | 100 | $105K | 100% |
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |